Origin Biologics
Simon Berry is a seasoned executive with significant experience in the biotechnology sector. As the Chief Executive Officer and co-founder of Australian Biotechnologies since April 2012, Simon has played a pivotal role in the company's growth and development. Additionally, Simon serves as the CEO of Origin Biologics since August 2018 and holds a position as Director at Origin Biologics. Simon Berry's educational background includes attendance at St Joseph's College, initiated in 1985.
This person is not in any teams
This person is not in any offices
Origin Biologics
Origin Biologics is a regenerative medicine company that develops and delivers innovative allograft and regenerative clinical solutions designed to support and maximize the body’s regenerative and healing potential. Our ultimate goal is to improve patient outcomes and quality of life while honoring and valuing the gift of donation.